Bionano reports fourth quarter and full-year 2024 results and provides revenue outlook for 2025

San diego, march 31, 2025 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today reported financial results for the fourth quarter and full year ended december 31, 2024 and revenue outlook for 2025. “2024 has been an important year for bionano.

BNGO Ratings Summary

BNGO Quant Ranking